Epidemiology, prevention and management of ventriculoperitoneal shunt infections in children.
about
Paediatric ventriculoperitoneal shunt infection caused by Actinomyces neuii.Coagulase-negative staphylococci: update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus.Ventricular shunt infections: immunopathogenesis and clinical management.Endoscopic third ventriculostomy in patients with shunt malfunction.Factors affecting ventriculoperitoneal shunt survival in adult patients.Intraparenchymal pericatheter cyst as a complication of a ventriculo-peritoneal shunt in a premature infantTransient binocular visual loss: a rare presentation of ventriculoperitoneal shunt malfunction.Low-pressure valves in hydrocephalic children: a retrospective analysis.Ethical Dilemmas in Postnatal Treatment of Severe Congenital HydrocephalusIL-10 plays an important role in the control of inflammation but not in the bacterial burden in S. epidermidis CNS catheter infectionThe dilemma of complicated shunt valves: How to identify patients with posthemorrhagic hydrocephalus after aneurysmatic subarachnoid hemorrhage who will benefit from a simple valve?Hydrocephalus in toddlers: the place of shunts in sub-Sahara African countries.Microbiology and treatment of cerebrospinal fluid shunt infections in children.Clinical practice audit concerning antimicrobial prophylaxis in paediatric neurosurgery: results from a German paediatric oncology unit.Ventriculoperitoneal shunt 30-day failure rate: a retrospective international cohort study.Ventriculoperitoneal shunts in neonates: a retrospective study of outcomes with antibiotic-impregnated catheters and a modified peri-operative antibiotic protocol.Early ventriculoperitoneal shunt infection.VP-shunt dysfunction caused by malaria CNS infection.Using individualized opening pressure to determine the optimal setting of an adjustable proGAV shunt in treatment of hydrocephalus in infants.Use of programmable versus nonprogrammable shunts in the management of normal pressure hydrocephalus: A multicenter retrospective study with cost-benefit analysis in Turkey.Evaluation of an institutional guideline for the treatment of cerebrospinal fluid shunt-associated infections.Significant reduction of shunt infection rate in children below 1 year of age after implementation of a perioperative protocol.Ventriculoperitoneal shunt complications in hydrocephalus patients with intracranial tumors: an analysis of relevant risk factors.Analysis of factors affecting ventriculoperitoneal shunt survival in pediatric patients.The Impact of a Pediatric Shunt Surgery Checklist on Infection Rate at a Single Institution.Topical vancomycin reduces the cerebrospinal fluid shunt infection rate: A retrospective cohort study.Simultaneous ventriculoperitoneal shunt removal and endoscopic third ventriculostomy for three patients previously treated for intracranial germ cell tumors more than 20 years ago.Ventriculoperitoneal shunt infection with Listeria innocua.Use of linezolid in neonatal and pediatric inpatient facilities--results of a retrospective multicenter survey.
P2860
Q33691826-E67A29E9-4D50-494A-BEF6-88A27BFD8807Q34181643-A20EC9A0-90A7-4010-A613-C3BE7BC765B9Q34619785-0D9F4A4D-AB68-4EB9-B005-51BC1BFEC7B3Q34993795-7B909B10-7B9B-425F-AFD8-3A3CB42EB53CQ35114076-E6BDA32C-A449-49CA-BF45-C8EFFF8CE9E7Q35502951-204596B4-02C4-4609-8BCF-C2E834C682E1Q35614233-C4B5BE31-2998-4785-9722-718F29BA4282Q35772528-2A1860BC-BFC6-45DB-98B9-DF7C1346B068Q36486031-31EAECA6-C3D8-460A-AF8A-DC519EAD985DQ37340589-2D6EC73C-7623-410B-B19D-8A54C63E4306Q38366017-0ECC12C0-C95D-4C82-97A7-76B6891B68EBQ38974440-800AD53C-B880-4478-9412-3BA589712F8BQ39144222-9CE2D19D-B3A2-435D-B16E-09D12938D4A0Q39206142-E441845C-9B49-48E1-B279-D83759B9985DQ39340495-2973D371-483E-4D10-B8AA-A736B32FCC00Q40082239-BBFF6E91-605B-4352-8526-00967E6DA9C7Q40709451-7A7EC4AF-85A3-4ED4-92AD-E53DE74F8D07Q40987375-7A2204D0-A201-4159-A8A6-E988DF44B3DBQ41122485-CFCF0795-15D2-4F2D-B558-33C4BB5E994DQ42037780-23967732-FB53-4962-A0DC-9CEA42C8914CQ43662262-992A19AE-3FC2-4691-BE5C-4B1E0E42A151Q44179278-41B7D198-CEAF-43E0-88DC-099D9F45CA98Q45376769-98C283C2-7387-4B59-945B-90FDCCAE6361Q45853221-C797D54D-83C3-45DC-8382-FC7C0FE3A217Q47762047-A63D2A77-B4CF-4959-92D8-F067B2B536FBQ48283947-CD4F357F-BF67-433F-905D-B767A73D5661Q48823889-88C4A760-C962-4EFE-B10C-3085C0CC8E37Q51164507-9EC1143F-1F13-4260-8278-A83C383FE02DQ51505589-8059B6BC-769A-4435-9C9A-60105C092823
P2860
Epidemiology, prevention and management of ventriculoperitoneal shunt infections in children.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Epidemiology, prevention and m ...... shunt infections in children.
@en
Epidemiology, prevention and m ...... shunt infections in children.
@nl
type
label
Epidemiology, prevention and m ...... shunt infections in children.
@en
Epidemiology, prevention and m ...... shunt infections in children.
@nl
prefLabel
Epidemiology, prevention and m ...... shunt infections in children.
@en
Epidemiology, prevention and m ...... shunt infections in children.
@nl
P2093
P356
P1476
Epidemiology, prevention and m ...... shunt infections in children.
@en
P2093
Arne Simon
Christian von der Brelie
Julia Prusseit
Matthias Simon
Sebastian Volz
P304
P356
10.1159/000257520
P577
2009-11-11T00:00:00Z